Skip to main content

Cristina Guirao Martinez

Institutions of which they are part

Research technician
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Cristina Guirao Martinez

Institutions of which they are part

Research technician
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert, Olalla Pancorbo Rosal, Claudia Meza Burgos
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

TRUSTroke: TRUSTWORTHY PREDICTION OF STROKE OUTCOME ON A FEDERATED LEARNING INFRASTRUCTURE

IP: Carlos Molina Cateriano
Collaborators: Estela Sanjuan Menendez, Laura Rivera Sanchez, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Maria del Pilar Saez Hernandez, Maria Baladas Orti, Cristina Guirao Martinez, Riccardo Cipollina
Funding agency: EUROPEAN COMMISSION
Funding: 760000
Reference: TRUSTROKE_HE-HLTH-STAYHLTH2022
Duration: 01/05/2023 - 30/04/2027

VALIDATE: Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Maria Victoria Sala Sanz de Madrid, Cristina Guirao Martinez, Claudia Meza Burgos, Federica Rizzo, Ester Sanchez Gavilan, David Rodriguez Luna
Funding agency: EUROPEAN COMMISSION
Funding: 567950
Reference: VALIDATE_HE-HLTH-DISEASE21
Duration: 01/05/2022 - 30/04/2026

Related news

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

Related professionals

Masotto , Barbara

Masotto , Barbara

Predoctoral researcher
Genetics Medicine
Read more
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Rheumatology
Read more
Pablo Eduardo Tobias Castillo

Pablo Eduardo Tobias Castillo

Predoctoral researcher
Cardiovascular Diseases
Read more
Carmen Folch Badiella

Carmen Folch Badiella

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.